Article - August 6, 2008 - Burlington Times News
LabCorp announces partnership with the National Kidney Foundation
Burlington-based LabCorp announced a national effort to combat chronic kidney disease in North America Wednesday.
U.S. Sen. Elizabeth Dole, R-N.C., a supporter of newly passed legislation to fight CKD, and representatives of the National Kidney Foundation joined executives of LabCorp at an event in Kannapolis to announce the new initiative.
The cornerstone of the effort is a program offered by LabCorp's Litholink subsidiary that provides highly nuanced, patient-specific clinical guidance to physicians based on the National Kidney Foundation's Kidney Disease Outcome Quality Initiative. This program is designed to support nephrologists as well as internal medicine, family practitioners, general practitioners, nurse practitioners and all other healthcare professionals who provide primary care to patients.
Dole recently voted for the passage of the Medicare Improvements for Patients and Providers Act of 2008, which included provisions to fight CKD. It became law last month when Congress overrode a veto by President Bush.
"LabCorp is pleased to be the first clinical lab to offer such a unique program for CKD," said David P. King, president and CEO of LabCorp. "With the launch of our CKD Education and Treatment Program, Litholink has developed another new and critically important tool for physicians. Our partnership with the National Kidney Foundation and other leaders in fighting CKD demonstrates the unique role that the lab can play in chronic disease prevention.
Page Information
|
Wiki Information |
Recent PBwiki Blog Posts |